Alterations in orexin signaling have been linked to sleep disturbances in Alzheimer’s disease, with increased orexin levels correlating with disrupted REM sleep and accelerated cognitive decline [87]. This evidence concerns the gene HCRT and early-onset autosomal dominant Alzheimer disease.